convoy therapeutics
Tucson · Founded 2011
About convoy therapeutics
Convoy Therapeutics, a subsidiary of ACTUS Biotechnologies, was founded in 2011 based upon the proprietary Skin-Penetrating And Cell Entering (SPACE) peptide technology developed by Professor Samir Mitragotri and his laboratory at University of California at Santa Barbara. The company is focused on enhancing the patient experience using its proprietary platform technology and aggressively advancing this platform technology through the research and development process.
Company Facts
- Founded: 2011
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Last round: Series Unknown (May 2012)
- Website: convoytx.com
- Phone: 520-333-6844
Social Profiles
Canonical: https://fsome.com/organization/convoy-therapeutics-8305620 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.